EDIT vs MOS
Editas Medicine Inc (EDIT) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
EDIT currently screens at market cap $375.2M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the EDIT and MOS stock pages for the full models.
Not investment advice.